Vivanza Biosciences Q4 Results Live : Vivanza Biosciences declared their Q4 results on 30 Apr, 2024. The topline decreased by 46.32% & the loss increased by 309.27% YoY.
As compared to the previous quarter the revenue declined by 32.6% and the loss increased by 305.83%.
The Selling, general & administrative expenses declined by 9.41% q-o-q & increased by 17.49% Y-o-Y.
The operating income was down by 153.39% q-o-q & decreased by 3344.44% Y-o-Y.
The EPS is ₹-0.1 for Q4 which decreased by 285.65% Y-o-Y.
| Period | Q4 | Q3 | Q-o-Q Growth | Q4 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 4.42 | 6.56 | -32.6% | 8.24 | -46.32% |
| Selling/ General/ Admin Expenses Total | 0.1 | 0.11 | -9.41% | 0.09 | +17.49% |
| Depreciation/ Amortization | 0.01 | 0 | +1328.57% | 0 | +1566.67% |
| Total Operating Expense | 4.58 | 6.27 | -27.01% | 8.24 | -44.47% |
| Operating Income | -0.15 | 0.29 | -153.39% | -0 | -3344.44% |
| Net Income Before Taxes | -0.28 | 0.21 | -234.03% | 0.01 | -2004.14% |
| Net Income | -0.42 | 0.21 | -305.83% | -0.1 | -309.27% |
| Diluted Normalized EPS | -0.1 | 0.05 | -300% | -0.03 | -285.65% |
FAQs
Question : What is the Q4 profit/Loss as per company?
Ans : ₹-0.42Cr
Question : What is Q4 revenue?
Ans : ₹4.42Cr
Stay updated on quarterly results with our results calendar
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it’s all here, just a click away! Login Now!
Download The Mint News App to get Daily Market Updates & Live Business News.
More
Less
Published: 03 May 2024, 02:34 AM IST
Omprakash Tiwary is a business writer who delves into the intricacies of the corporate world. With a focus on finance and economic landscape. He offers readers valuable insights into market trends, entrepreneurship, and economic developments.
